Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: 10-Year Follow-Up of a Randomized Controlled Trial.

Author: Saito, Yoshihiko MD, PhD; Okada, Sadanori MD, PhD; Ogawa, Hisao MD, PhD; Soejima, Hirofumi MD, PhD; Sakuma, Mio MD, PhD; Nakayama, Masafumi MD, PhD; Doi, Naofumi MD, PhD; Jinnouchi, Hideaki MD, PhD; Waki, Masako MD, PhD; Masuda, Izuru MD, PhD; Morimoto, Takeshi MD, PhD; For the JPAD Trial Investigators

Page: 659-670

http://ift.tt/2lDT3Id